Nuclear Medicine and Biology

Article	Citations
Review on 99mTc radiopharmaceuticals with emphasis on new advancements	81
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations	48
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion	43
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far	41
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historica	37
Production, purification and availability of 211At: Near term steps towards global access	37
A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3	35
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours	29
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology	29
Alpha emitting nuclides for targeted therapy	26
The development of 11C-carbonylation chemistry: A systematic view	25
Gold nanoparticles meet medical radionuclides	22
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals	21
Neutron-activated theranostic radionuclides for nuclear medicine	20
Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides	19
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18	18
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb	17
18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging	17
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent	17
Auger: The future of precision medicine	16
Automated production of [18F]SiTATE on a Scintomics GRP™ platform for PET/CT imaging of neuroendocrine tumors	16
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue	15
The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence	15
A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr – In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian ca	15
Review: PET imaging with macro- and middle-sized molecular probes	15

Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11	14
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience	14
Combination radionuclide therapy: A new paradigm	13
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [68Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies	13
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models	13
Evaluation of [225Ac]Ac-DOTA-anti-VLA-4 for targeted alpha therapy of metastatic melanoma	13
Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging	12
[89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure	12
Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors	11
A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models	11
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production	11
In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration	11
Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging	11
Radioarsenic: A promising theragnostic candidate for nuclear medicine	11
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy	10
Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1	10
Radiolabeling with [11C]HCN for Positron emission tomography	10
Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease	10
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer	10
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain	10
Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras	9
Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb	9
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer	9
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET	9
New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles	9
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals	9
Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model	9
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody	9
[99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas	8
Bismuth chelation for targeted alpha therapy: Current state of the art	8
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging	8
High-yield cyclotron production of 203Pb using a sealed 205Tl solid target	8
Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers	8
45Ti targeted tracers for PET imaging of PSMA	8
Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins	8
A decade of ubiquicidin development for PET imaging of infection: A systematic review	8
Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease	7
AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions	7
Training the next generation of radiopharmaceutical scientists	7
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model	7
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals	7
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain	7
Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac	7
Aryl isocyanide derivative for one-pot synthesis of purification-free 99mTc-labeled hexavalent targeting probe	7
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic	7
68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics	7
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications	6
[11C]phosgene: Synthesis and application for development of PET radiotracers	6
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons	6
A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation	6

Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma	6
[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma	6
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging	6
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu	6
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold	6
Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands	6
Passive and receptor mediated brain delivery of an anti-GFAP nanobody	6
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications	6
Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides	6
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines	6
Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs	6
EXIRAD-3D: Fast automated three-dimensional autoradiography	5
[68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair	5
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy	5
PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data	5
A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator	5
68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma	5
Immuno-imaging of ICAM-1 in tumours by SPECT	5
Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d2: A comparison with [18F]FDG	5
HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging	5
Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy	5
Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer	5
Plasma pharmacokinetic and metabolism of [18F]THK-5317 are dependent on sex	5
RETRACTED: Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors	5
Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain	5
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine	5
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation	5
18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach	5
Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guani	5
Radiochemical and biological properties of peptides designed to interact with EGF receptor: Relevance for glioblastoma	5
GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study	4
Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy	4
An original radio-biomimetic approach to synthesize radiometabolites for PET imaging	4
Brain pharmacokinetics and biodistribution of 11C-labeled isoproterenol in rodents	4
Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results	4
Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX	4
Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer	4
Tracer development for PET imaging of proteinopathies	4
News ways of understanding the complex biology of diabetes using PET	4
In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain	4
Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans	4
Development of a PET radioligand selective for cerebral amyloid angiopathy	4
Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713	4
Synthesis and evaluation of 6-[18F]fluoro-3-(pyridin-3-yl)-1H-indole as potential PET tracer for targeting tryptophane 2, 3-dioxygenase (TDO)	4
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations	4
Imaging niacin trafficking with positron emission tomography reveals in vivo monocarboxylate transporter distribution	4
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation	4
Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas	3
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM	3
Characterization of actinide resin for separation of 51,52gMn from bulk target material	3
Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies	3
Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer	3
Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging	3
Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta)	3
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)	3
Transport mechanism and affinity of [99mTc]Tc-mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells	3
A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept	3
Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO	3
First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor	3
Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model	3
Evaluation and selection of a lead diabody for interferon-γ PET imaging	3
Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics	3
Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [64Cu]Cu-NOTA-panitumumab F(ab′)2 alone or combined with radiosensitizing gemcitabine and the PARP inhibitor, rucaparib	3
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer	3
Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling	3
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy	3
Applying radiobiology to clinical molecular radiotherapy	3
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase	3
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes	3
Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy	3
Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators	3
Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals	2
Rapid detection of SARS-CoV-2 using a radiolabeled antibody	2
p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide	2
Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy	2
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4	2
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents?	2
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy	2
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply	2
Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2	2

Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage	2
Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides	2
Excitatory glutamate transporter EAAC1 as an important transporter of N-(2-[18F]fluoropropionyl)-L-glutamate in oncology PET imaging	2
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target	2
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer	2
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging	2
Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2	2
Automated production of [11C]butyrate for keto body PET imaging	2
Laminated holmium-166-containing electrospun bandages for use against skin cancer	2
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation	2
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer	2
GABAa receptor density alterations revealed in a mouse model of early moderate prenatal ethanol exposure using [18F]AH114726	2
Synthesis and characterization of [125I]TZ6544, a promising radioligand for investigating sphingosine-1-phosphate receptor 2	2
A new in silico approach to revolutionize CNS PET tracer design and enhance translational success	2
Radiopharmacy in Africa: current status and future directions	2
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain	2
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy	2
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues	2
Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers	2
Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers	2
First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer	2
Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography	2
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry	2
Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds	2
The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC	2
Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits	1
Rhenium and technetium complexes in extremely low oxidation states	1
Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands	1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG	1
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity	1
Integrin αvβ3 and EGFR dual-targeted [64Cu]Cu-NOTA-RGD-GE11 heterodimer for PET imaging in pancreatic cancer mouse model	1
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers	1
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist	1
Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen	1
Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic	1
Preparation of a multi-modal agent for sentinel lymph node mapping using Evans blue and 99mTc-labeled mannosylated human serum albumin conjugate	1
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo	1
The effect of base strengths on the radiochemical yields of S[18F]FB synthesis	1
Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome	1
A brief history of the Society of Radiopharmaceutical Sciences	1
Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)	1
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC	1
One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module	1
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3	1
Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO	1
Development and exploration of bifunctional chelating ligands for mercury-197m/g	1
Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43	1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours	1
Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches	1
Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer	1
[18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model	1
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor	1
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy	1
18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2	1
Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice	1
Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies	1
Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11	1
Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78	1
Imaging of microglia in post-stroke inflammation	1
Status of radiobiology in molecular radionuclide therapy – Hope for the future	1
Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nano	1
Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1	1
223Ra-radiolabeling: predicting stability using molecular modelling	1
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity	1
Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine	1
Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform	1
Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111	1
Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid	1
The synthesis and bioevaluation of a novel and brain penetrable PARP1 tracer [18F]Pamiparib in rodents and nonhuman primates	1
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice	1
18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media	1
Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles	1
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2	1
Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET	1
Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia	1
Radiolabeling and biological evaluation of functionalized spherical nucleic acids	1
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study	1
Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging	1
Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals	1
[99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers	1
Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation	1
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP	1
Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals	1
Copper-61 from liquid targets: optimized purification for GMP labelling	1
Production of 117mSn using Sb alloy targetry	1
Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis	1
Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid	1
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5	1
Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates	0
Abstract converted to P-85	0
[18F]Talazoparib: a novel potential PET imaging agent of PARP	0
Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-188	0
Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands	0
Development of targeted 161Tb-radiolabeled nanoparticles	0
Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers	0